Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

3.2K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
3.2K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

291
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
291
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

4.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.5K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

6.9K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
6.9K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

64
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
64

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Aristolochic Acid-Induced Nephrotoxicity: Molecular Mechanisms and Potential Protective Approaches.

International journal of molecular sciences·2020
Same author

Structural insights into immunoglobulin M.

Science (New York, N.Y.)·2020
Same author

Mutations of two FERONIA-like receptor genes enhance rice blast resistance without growth penalty.

Journal of experimental botany·2020
Same author

Receptor kinase FERONIA regulates flowering time in Arabidopsis.

BMC plant biology·2020
Same author

Dual-hybrid direct random phase approximation and second-order screened exchange with nonlocal van der Waals correlations for noncovalent interactions.

Journal of computational chemistry·2020
Same author

Genetic and functional analysis of two missense mutations in CD46 predispose to postpartum atypical hemolytic uremic syndrome.

Clinica chimica acta; international journal of clinical chemistry·2020

相关实验视频

Updated: Jul 17, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.8K

用于剂量确定试验的贝叶斯层次模型,包括历史数据.

Linxi Han1, Qiqi Deng2, Zhangyi He3

  • 1School of Mathematics, University of Bristol, Bristol, UK.

Journal of biopharmaceutical statistics
|September 7, 2023
PubMed
概括

这项研究引入了一种新的贝叶斯方法,通过结合多个剂量组的历史数据来改进剂量发现试验. 这种方法旨在减少样本大小,同时保持药物开发中的统计能力.

关键词:
贝叶斯的等级框架是贝叶斯的等级框架.剂量检测方法 剂量检测方法试验之间的异质性.过去的借贷情况

更多相关视频

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

相关实验视频

Last Updated: Jul 17, 2025

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.8K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

科学领域:

  • 生物统计学 生物统计学
  • 药学指标 (Pharmacometrics) 是一个指标.
  • 临床试验设计 临床试验设计

背景情况:

  • 多重比较程序和建模 (MCPMod) 对于剂量确定研究是有效的,但由于其频率主义性质,它难以将历史数据纳入.
  • 现有的贝叶斯MCPMod (BMCPMod) 可以结合历史的安慰剂数据,但不能结合活性剂量组的数据.

研究的目的:

  • 为剂量确定研究开发贝叶斯层次框架,该框架将多个剂量组 (安慰剂和活性剂) 的历史数据纳入.
  • 模拟试验间的预后和预测异质性,特别是当试验效应大小不同时.
  • 为了减少剂量检测试验中所需的样本大小,同时保持统计能力.

主要方法:

  • 开发了贝叶斯层次模型来整合来自不同剂量组的历史数据.
  • 考虑了剂量组反应和试验间异质性 (预后和预测) 之间的关系.
  • 应用框架以优化剂量检测研究设计的效率.

主要成果:

  • 拟议的贝叶斯框架成功地结合了多个剂量组的历史数据.
  • 该模型有效地处理试验间的异质性,容纳不同的效果大小.
  • 在剂量确定研究中,已证明减少样本大小的潜力.

结论:

  • 新的贝叶斯方法通过利用来自多个来源的历史数据来增强MCPMod技术.
  • 这种方法提供了一个灵活而强大的工具,用于设计更有效的剂量检测临床试验.
  • 促进了强大的剂量选择,同时尽量减少患者数量和资源分配.